Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

Science 337 (6102): 1684-1688

Copyright © 2012 by the American Association for the Advancement of Science

Mycobacterial Disease and Impaired IFN-{gamma} Immunity in Humans with Inherited ISG15 Deficiency

Dusan Bogunovic,1 Minji Byun,1 Larissa A. Durfee,2,* Avinash Abhyankar,1,* Ozden Sanal,3,* Davood Mansouri,4,* Sandra Salem,5,* Irena Radovanovic,5 Audrey V. Grant,6 Parisa Adimi,4 Nahal Mansouri,1,4 Satoshi Okada,1 Vanessa L. Bryant,1 Xiao-Fei Kong,1 Alexandra Kreins,1 Marcela Moncada Velez,1 Bertrand Boisson,1 Soheila Khalilzadeh,4 Ugur Ozcelik,3 Ilad Alavi Darazam,4 John W. Schoggins,7 Charles M. Rice,7 Saleh Al-Muhsen,8,9 Marcel Behr,10 Guillaume Vogt,1,6 Anne Puel,6 Jacinta Bustamante,6,11,{dagger} Philippe Gros,5,{dagger} Jon M. Huibregtse,2,{dagger} Laurent Abel,1,6,{dagger} Stéphanie Boisson-Dupuis,1,6 Jean-Laurent Casanova1,6,12,{ddagger}

Abstract: ISG15 is an interferon (IFN)-α/β–inducible, ubiquitin-like intracellular protein. Its conjugation to various proteins (ISGylation) contributes to antiviral immunity in mice. Here, we describe human patients with inherited ISG15 deficiency and mycobacterial, but not viral, diseases. The lack of intracellular ISG15 production and protein ISGylation was not associated with cellular susceptibility to any viruses that we tested, consistent with the lack of viral diseases in these patients. By contrast, the lack of mycobacterium-induced ISG15 secretion by leukocytes—granulocyte, in particular—reduced the production of IFN-{gamma} by lymphocytes, including natural killer cells, probably accounting for the enhanced susceptibility to mycobacterial disease. This experiment of nature shows that human ISGylation is largely redundant for antiviral immunity, but that ISG15 plays an essential role as an IFN-{gamma}–inducing secreted molecule for optimal antimycobacterial immunity.

1 St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY, USA.
2 Section of Molecular Genetics and Microbiology, Institute for Cellular and Molecular Biology, The University of Texas at Austin, Austin, TX 78712, USA.
3 Immunology Division and Pediatric Chest Disease Department, Hacettepe University Children’s Hospital, 06100 Ankara, Turkey.
4 Division of Infectious Diseases and Clinical Immunology, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Teheran, Iran.
5 Department of Biochemistry, McGill University, Montreal, Canada.
6 Laboratory of Human Genetics of Infectious Diseases, Necker Branch, Institut National de la Santé et de la Recherche Médicale, U980, University Paris Descartes, Necker Medical School, 75015 Paris, France.
7 Center for the Study of Hepatitis C, Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, NY, USA.
8 Prince Naif Center for Immunology Research, Department of Pediatrics, College of Medicine, King Saud University, Riyadh, 11211, Saudi Arabia.
9 Department of Pediatrics, King Faisal Specialist Hospital and Research Center, Riyadh, 11211, Saudi Arabia.
10 Research Institute, McGill University Health Center, Montreal, Canada.
11 Center for the Study of Primary Immunodeficiencies, Assistance Publique–Hopitaux de Paris, Necker Hospital, Paris, France.
12 Pediatric Hematology-Immunology Unit, Necker Hospital, 75015 Paris, France.

* These authors contributed equally to this work.

{dagger} These authors contributed equally to this work.

{ddagger} To whom correspondence should be addressed. E-mail: casanova{at}rockefeller.edu


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis.
Y. Mizoguchi, M. Tsumura, S. Okada, O. Hirata, S. Minegishi, K. Imai, N. Hyakuna, H. Muramatsu, S. Kojima, Y. Ozaki, et al. (2014)
J. Leukoc. Biol. 95, 667-676
   Abstract »    Full Text »    PDF »
Distinct T-Cell Responses When BCG Vaccination Is Delayed From Birth to 6 Weeks of Age in Ugandan Infants.
F. Lutwama, B. M. Kagina, A. Wajja, F. Waiswa, N. Mansoor, S. Kirimunda, E. J. Hughes, N. Kiwanuka, M. L. Joloba, P. Musoke, et al. (2014)
The Journal of Infectious Disease 209, 887-897
   Abstract »    Full Text »    PDF »
ISG15 Is Counteracted by Vaccinia Virus E3 Protein and Controls the Proinflammatory Response against Viral Infection.
B. Eduardo-Correia, C. Martinez-Romero, A. Garcia-Sastre, and S. Guerra (2014)
J. Virol. 88, 2312-2318
   Abstract »    Full Text »    PDF »
Clinical Features of Candidiasis in Patients With Inherited Interleukin 12 Receptor {beta}1 Deficiency.
M. Ouederni, O. Sanal, A. Ikinciogullari, I. Tezcan, F. Dogu, I. Sologuren, S. Pedraza-Sanchez, M. Keser, G. Tanir, C. Nieuwhof, et al. (2014)
Clinical Infectious Diseases 58, 204-213
   Abstract »    Full Text »    PDF »
TB or Not TB: That Is No Longer the Question.
R. L. Modlin and B. R. Bloom (2013)
Science Translational Medicine 5, 213sr6
   Full Text »    PDF »
Vaccinia virus immune evasion: mechanisms, virulence and immunogenicity.
G. L. Smith, C. T. O. Benfield, C. Maluquer de Motes, M. Mazzon, S. W. J. Ember, B. J. Ferguson, and R. P. Sumner (2013)
J. Gen. Virol. 94, 2367-2392
   Abstract »    Full Text »    PDF »
Partial IFN-{gamma}R2 deficiency is due to protein misfolding and can be rescued by inhibitors of glycosylation.
M. Moncada-Velez, R. Martinez-Barricarte, D. Bogunovic, X.-F. Kong, L. Blancas-Galicia, C. Tirpan, G. Aksu, Q. B. Vincent, B. Boisson, Y. Itan, et al. (2013)
Blood 122, 2390-2401
   Abstract »    Full Text »    PDF »
Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis.
O. Hirata, S. Okada, M. Tsumura, R. Kagawa, M. Miki, H. Kawaguchi, K. Nakamura, S. Boisson-Dupuis, J.-L. Casanova, Y. Takihara, et al. (2013)
Haematologica 98, 1641-1649
   Abstract »    Full Text »    PDF »
Zebrafish ISG15 Exerts a Strong Antiviral Activity against RNA and DNA Viruses and Regulates the Interferon Response.
C. Langevin, L. M. van der Aa, A. Houel, C. Torhy, V. Briolat, A. Lunazzi, A. Harmache, M. Bremont, J.- P. Levraud, and P. Boudinot (2013)
J. Virol. 87, 10025-10036
   Abstract »    Full Text »    PDF »
New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.
B. Soltesz, B. Toth, N. Shabashova, A. Bondarenko, S. Okada, S. Cypowyj, A. Abhyankar, G. Csorba, S. Tasko, A. K. Sarkadi, et al. (2013)
J. Med. Genet. 50, 567-578
   Abstract »    Full Text »    PDF »
Ribosomal Protein SA Haploinsufficiency in Humans with Isolated Congenital Asplenia.
A. Bolze, N. Mahlaoui, M. Byun, B. Turner, N. Trede, S. R. Ellis, A. Abhyankar, Y. Itan, E. Patin, S. Brebner, et al. (2013)
Science 340, 976-978
   Abstract »    Full Text »    PDF »
Diversity of Ubiquitin and ISG15 Specificity among Nairoviruses' Viral Ovarian Tumor Domain Proteases.
G. C. Capodagli, M. K. Deaton, E. A. Baker, R. J. Lumpkin, and S. D. Pegan (2013)
J. Virol. 87, 3815-3827
   Abstract »    Full Text »    PDF »
Autoantibodies against cytokines: back to human genetics.
A. Puel and J.-L. Casanova (2013)
Blood 121, 1246-1247
   Full Text »    PDF »
Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease.
X.-F. Kong, G. Vogt, Y. Itan, A. Macura-Biegun, A. Szaflarska, D. Kowalczyk, A. Chapgier, A. Abhyankar, D. Furthner, C. Djambas Khayat, et al. (2013)
Hum. Mol. Genet. 22, 769-781
   Abstract »    Full Text »    PDF »
Fighting mycobacteria through ISGylation.
C. Pohl and I. Dikic (2012)
EMBO Rep. 13, 872-873
   Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882